Press release
Cardiovascular Disease Rates Fuel Expansion Of POC Coagulation Testing Market: Transformative Forces Shaping the Point-of-Care (POC) Coagulation Testing Market Landscape in 2025
Point of Care POC Coagulation Testing
What Will the Point-of-Care (POC) Coagulation Testing Industry Market Size Be by 2025?
The market size of point-of-care (POC) coagulation testing has been experiencing robust growth in recent years. The market is projected to increase from $1.18 billion in 2024 to $1.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The surge in historical growth is linked to factors such as increased patient demand, the growing popularity of point-of-care testing, the high dependability of coagulation status on pt test, the incorporation of automation and electronic health records (EHRs), as well as the escalating occurrence of cardiovascular diseases and blood disorders.
What's the Long-Term Growth Forecast for the Point-of-Care (POC) Coagulation Testing Market Size Through 2029?
In the forthcoming years, the point-of-care (POC) coagulation testing market is projected to experience a stable surge in its size. The market is anticipated to reach $1.48 billion by 2029, progressing at a compound annual growth rate (CAGR) of 4.2%. The expansion projections for the forecast period can be linked to a broadening scope in healthcare, escalating needs in homecare environments, an uptick in chronic blood disorders, patients' preference for quick and precise testing, along with a boost in the point-of-care testing. During the forecast period, prime trends will include technological progression, a high demand in developed nations, widening applications in healthcare, the influence of COVID-19, and the rise of multiplexing POC diagnostics.
View the full report here:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report
What Are the Key Growth Drivers Fueling the Point-of-Care (POC) Coagulation Testing Market Expansion?
The point-of-care (POC) coagulation testing market is set to grow due to the increasing prevalence of cardiovascular diseases. Disorders such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease fall under the umbrella of cardiovascular diseases (CVDs). These conditions affect the heart and blood vessels. POC coagulation testing plays a crucial role in the management of CVDs by providing instant data on coagulation status. This supports decisive action on coagulation measures, mitigating the chance of bleeding complications post-heart surgery. The World Heart Federation, a non-governmental organization based in Switzerland, reported in October 2022 that the mortality rate from cardiovascular disease may rise-death toll from CVDs estimated to increase from about 18.9 million in 2020 to more than 22.2 million by 2030, and could reach up to 32.3 million by 2050. Thus, with the increasing occurrence of cardiovascular diseases, the demand for point-of-care (POC) coagulation testing in the market is driving its expansion.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp
What Are the Key Trends Driving Point-of-Care (POC) Coagulation Testing Market Growth?
Leading organizations in the point-of-care (POC) coagulation testing sector are focusing on strategic alliances to secure a competitive advantage. These alliances are formal divulgations between two or more parties, with a focus on working cooperatively to reach specific, mutually beneficial objectives. For example, Jana Care, an American biomarker assay development company, entered into a strategic partnership with Roche Diagnostics, a Swiss firm known for developing diagnostic tests, tools, and digital health solutions. This alliance, formed in January 2023, is focused on creating and distributing a novel point-of-care blood testing platform intended for screening chronic kidney disease and heart failure. The revolutionary platform will offer patients the convenience of performing blood tests at home while clinicians can review the results remotely.
How Is the Point-of-Care (POC) Coagulation Testing Market Segmented?
The point-of-care (POC) coagulation testing market covered in this report is segmented -
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp
Which Companies Are Leading the Charge in Point-of-Care (POC) Coagulation Testing Market Innovation?
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc
Which Regions Are Leading the Global Point-of-Care (POC) Coagulation Testing Market in Revenue?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiovascular Disease Rates Fuel Expansion Of POC Coagulation Testing Market: Transformative Forces Shaping the Point-of-Care (POC) Coagulation Testing Market Landscape in 2025 here
News-ID: 4125988 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for POC
Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market?
The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited…
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market?
The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records…
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes.
Point-of-Care Molecular Diagnostic Platform
1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components:
• Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics.
• Device: The 1POT™ Duo…
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage
POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more.
The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow…
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Point of Care (POC) Coagulation Testing Devices…
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652
The report provides a comprehensive analysis of company profiles listed below:
- Abbott
- Biomerieux
- Danaher
- F.…
